Search Results

Search Constraints

Start Over
Filtering by: Creator Dewaraja, Yuni K. Remove constraint Creator: Dewaraja, Yuni K. Discipline Health Sciences Remove constraint Discipline: Health Sciences

Search Results

  • Y-90 PET/CT & SPECT/CT and Corresponding Contours Dataset 31JULY2020

    work
    Creator:
    Van, Benjamin J. and Dewaraja, Yuni K.
    Description:
    Interest in quantitative imaging of Y-90 is growing because transarterial radioembolization (RE) with Y-90 loaded microspheres is a promising and minimally invasive treatment that is FDA approved for unresectable primary and metastatic liver tumors. These cancers are a leading cause of cancer mortality and morbidity. Radioembolization is a therapy that irradiates liver tumors with radioactive microspheres administered through a microcatheter placed in the hepatic arterial vasculature. Radioembolization is based on the principle that healthy liver and tumor are mainly vascularized by the portal vein and the hepatic artery respectively. As a result, radioactive microspheres are preferentially located in the lesions after they are administered via the hepatic artery.
    Keyword:
    Y-90, PET, SPECT, CT, Segmentation, Organ, Tumor, Label, Microsphere, Radioembolization, and SIRT
    Citation to related publication:
    Van, B. J., Dewaraja, Y. K., Sangogo, M. L., & Mikell, J. K. (2021). Y-90 SIRT: Evaluation of TCP variation across dosimetric models. EJNMMI Physics, 8(1), 45.  https://doi.org/10.1186/s40658-021-00391-6
    Discipline:
    Health Sciences

  • Y-90 patients PET/CT & SPECT/CT and corresponding contours dataset

    work
    Creator:
    Lim, Hongki and Dewaraja, Yuni K.
    Description:
    Interest in quantitative imaging of Y-90 is growing because transarterial radioembolization (RE) with Y-90 loaded microspheres is a promising and minimally invasive treatment that is FDA approved for unresectable primary and metastatic liver tumors. These cancers are a leading cause of cancer mortality and morbidity. Radioembolization is a therapy that irradiates liver tumors with radioactive microspheres administered through a microcatheter placed in the hepatic arterial vasculature. Radioembolization is based on the principle that healthy liver and tumor are mainly vascularized by the portal vein and the hepatic artery respectively. As a result, radioactive microspheres are preferentially located in the lesions after they are administered via the hepatic artery.
    Keyword:
    Y-90, PET, SPECT, CT, Segmentation, Organ, Tumor, Label
    Citation to related publication:
    Van, B. J., Dewaraja, Y. K., Sangogo, M. L., & Mikell, J. K. (2021). Y-90 SIRT: Evaluation of TCP variation across dosimetric models. EJNMMI Physics, 8(1), 45.  https://doi.org/10.1186/s40658-021-00391-6
    Discipline:
    Health Sciences

  • Lu-177 patients CT images and contours dataset for medical image segmentation

    work
    Creator:
    Lim, Hongki and Dewaraja, Yuni K.
    Description:
    Internally administered targeted radionuclide therapy (TRT) with radio-labelled targeting molecules that deliver cytotoxic radiation to tumor has been used successfully to treat multiple cancers. Lu-177, used increasingly in TRT, emits both beta particles that deliver the therapeutic effect. FDA recently approved a fixed activity (4 cycles of 7.4 GBq/cycle as in NETTER -1) administered every 8 weeks. With the patient studies under this treatment, we collected CT images and corresponding volume of interest (organs, lesions) contours.
    Keyword:
    Lu-177, CT, Segmentation, Organ, Tumor, Label
    Discipline:
    Health Sciences